Showing results (1771-1780 of 1,960) with videos related to

Sort By:
Pageof 196
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphomaMatthew T Drake, Matthew J Maurer, Brian K Link, et al.
Transplantation and Cellular Therapy|January 1, 2026
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin LymphomaSairah Ahmed, Ambuj Kumar, Paul Carpenter, et al.
BMJ Open|October 21, 2025
Free school meals, diet quality and food insecurity in secondary school students: protocol for a multiple-methods study - the CANTEEN studyEmma Alving-Jessep, Miranda Pallan, Ellie Ansell, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancerByoung Chul Cho, Melissa Johnson, Jair Bar, et al.
Neuro-Oncology|October 28, 2017
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastomaHui K Gan, David A Reardon, Andrew B Lassman, et al.
Leukemia & Lymphoma|January 12, 2018
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphomaMohamad Bassam Sonbol, Talal Hilal, Amylou C Dueck, et al.
The New England Journal of Medicine|July 13, 2022
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's LymphomaStephen M Ansell, John Radford, Joseph M Connors, et al.
JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Journal of the American Heart Association|October 30, 2018
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AFJeffrey B Washam, DaJuanicia N Holmes, Laine E Thomas, et al.
Pageof 196